Contact us: +91 9550333722 040 - 40102781
Structured search
India
Choose your country
Different countries will display different contents
Try our best to find the right business for you.
My chemicalbook

Welcome back!

HomeProduct name listDabigatran etexilate

Dabigatran etexilate

  • CAS NO.:211915-06-9
  • Empirical Formula: C34H41N7O5
  • Molecular Weight: 627.73
  • MDL number: MFCD22422841
  • EINECS: 606-722-8
  • SAFETY DATA SHEET (SDS)
  • Update Date: 2024-08-24 19:19:26
Dabigatran etexilate Structural

What is Dabigatran etexilate?

Absorption

Oral dabigatran has a bioavailability of 3-7%, although the relative bioavailability of dabigatran pellets is 37% higher than that for capsules and the bioavailability increases to 75% when the capsule shell is removed; dabigatran capsules should not be tampered with in any way prior to administration. The Cmax is achieved by one hour following oral dosing, which is extended to two hours if accompanied by a high-fat meal. Dabigatran can be taken with or without food. Dabigatran pharmacokinetics are approximately linear over a range of 10-400 mg in healthy adults and adult patients and it has an accumulation factor of two in adult and pediatric patients.

Toxicity

No human studies involving pregnancy, labor and delivery, nursing, or pediatrics. Geriatric patients are at higher risk of adverse effects than younger patients but the risk to benefit ratio is generally still favourable for older patients. Patients with a creatinine clearance of 15-30mL/min should have their doses of dabigatran etexilate reduced, and no data is available for patients with a creatinine clearance below 15mL/min.
In animal studies, dabigatran increases the rates of dead offspring and causes uterine and vaginal bleeding close to birth. Dabigatran may or may not be excreted in breast milk so the risk and benefit of stopping the drug or stopping breast feeding must be considered.

Description

Dabigatran etexilate is an anticoagulant drug developed and marketed by Boehringer Ingelheim. The parent compound, dabigatran, is a potent thrombin blocker, but it cannot be administered orally. Adding the hydrophobic carbohexoxy group (“etexilate”) to the imine nitrogen created an orally absorbable prodrug.

Background

Dabigatran etexilate is an oral prodrug that is hydrolyzed to the competitive and reversible direct thrombin inhibitor dabigatran. Dabigatran etexilate may be used to decrease the risk of venous thromboembolic events in patients in whom anticoagulation therapy is indicated. In contrast to warfarin, because its anticoagulant effects are predictable, lab monitoring is not necessary. Dabigatran etexilate was approved by the FDA in 2010.

Properties of Dabigatran etexilate

Melting point: 128-129°
Density  1.24±0.1 g/cm3(Predicted)
storage temp.  Sealed in dry,Store in freezer, under -20°C
solubility  DMSO (Slightly), Methanol (Slightly)
form  Solid
pka 9.88±0.46(Predicted)
color  White to Pale Yellow
Stability: Hygroscopic

Safety information for Dabigatran etexilate

Computed Descriptors for Dabigatran etexilate

Abamectin manufacturer

KARPSCHEM LABORATORIES PVT. LTD.

1Y
Phone:+917249203006
Whatsapp: +91 7249203006
product: 211915-06-9 Dabigatran Etexilate N-[[2-[[[4- [[[(Hexyloxy)carbonyl]amino]iminomethyl]phenyl]amino]methy l]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-β- Alanine Ethyl Ester 96%
Inquiry

Lee Pharma Ltd

1Y
Phone:+91-9849085929
Whatsapp: +91 9849085929
product: 211915-06-9 98%
Inquiry

Nosch Labs Pvt Ltd

1Y
Phone:+91-9948222287
product: Dabigatran etexilate 99%
Inquiry

HRV Global Life Sciences

1Y
Phone:+91-9820219686
Whatsapp: +91 9820219686
product: Dabigatran etexilate 211915-06-9 99%
Inquiry

Afton Pharma

1Y
Phone:+91-9712000202
Whatsapp: +91-9712000202
product: 211915-06-9 Dabigatran etexilate 98%
Inquiry

Chempifine Chemicals

1Y
Phone:+91-2225667766
product: 211915-06-9 98%
Inquiry

Dr. ASCRO Bio Sciences Private Limited

1Y
Phone:+undefined-+91 9182680914
Whatsapp: +91 9182680914
product: Dabigatran etexilate 98%
Inquiry

Rivashaa Agrotech Biopharma Pvt. Ltd.

1Y
Phone:+91-7926462688
product: Dabigatran etexilate 211915-06-9 98%
Inquiry

Cubane Pharmaceuticals LLP

1Y
Phone:+91-9825323764
Whatsapp: +91-9825323764
product: 211915-06-9 Dabigatran etexilate 99%
Inquiry

Related products of tetrahydrofuran

You may like

  • DABIGATRAN ETEXILATE 35%, 40.0%, 43%, 50% W/W PELLETS 211915-06-9 98%
    DABIGATRAN ETEXILATE 35%, 40.0%, 43%, 50% W/W PELLETS 211915-06-9 98%
    211915-06-9
    View Details
  • Dabigatran etexilate 99%
    Dabigatran etexilate 99%
    211915-06-9
    View Details
  • Dabigatran etexilate 95% CAS 211915-06-9
    Dabigatran etexilate 95% CAS 211915-06-9
    211915-06-9
    View Details
  • Dabigatran etexilate 98% CAS 211915-06-9
    Dabigatran etexilate 98% CAS 211915-06-9
    211915-06-9
    View Details
  • 211915-06-9 98%
    211915-06-9 98%
    211915-06-9
    View Details
  • Dabigatran etexilate 211915-06-9 98%
    Dabigatran etexilate 211915-06-9 98%
    211915-06-9
    View Details
  • Dabigatran etexilate 98% CAS 211915-06-9
    Dabigatran etexilate 98% CAS 211915-06-9
    211915-06-9
    View Details
  • Dabigatran etexilate CAS 211915-06-9
    Dabigatran etexilate CAS 211915-06-9
    211915-06-9
    View Details
Statement: All products displayed on this website are only used for non medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.